Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer

Fig. 6

Case report. A Score of the 25 drugs tested on CGR0039 PDO. B Oxaliplatin score for the 25 PDOs. C Lab value of ALP, ASAT, ALAT (liver function) ACE and CA 19–9 (tumor marker) blood levels collected from the biopsy date (day = 0) up to 50 days after the end of the CAPOX treatment. D CT-scan before and 2 months after the beginning of the CAPOX treatment. Red line delimits the peritoneal effusion before treatment which is not observed after 2 months of CAPOX treatment

Back to article page